Proliferation markers in tumours: interpretation and clinical value.
Open Access
- 1 October 1998
- journal article
- review article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 51 (10) , 716-724
- https://doi.org/10.1136/jcp.51.10.716
Abstract
No abstract availableThis publication has 139 references indexed in Scilit:
- The important prognostic value of Ki-67 expression as determined by image analysis in breast cancerZeitschrift für Krebsforschung und Klinische Onkologie, 1996
- Proliferating-cell nuclear antigen (PC10) immunolabelling and other proliferation indices as prognostic factors in breast cancerZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- Comparison of PCNA/cyclin immunohistochemistry with flow cytometric S-phase fraction in breast cancerBreast Cancer Research and Treatment, 1992
- Prognostic factors in axillary lymph node-negative (pN−) breast carcinomasEuropean Journal of Cancer and Clinical Oncology, 1991
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- Pathologic correlates of survival in 378 lymph node-negative infiltrating ductal breast carcinomas. Mitotic count is the best single predictorCancer, 1991
- A comparative study of histopathology, hormone receptors, peanut lectin binding, ki-67 immunostaining, and nucleolar organizer region-associated proteins in human breast cancerCancer, 1991
- Flow cytometric discrimination of mitotic nuclei by right‐angle light scatterCytometry, 1988
- Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variablesThe Journal of Pathology, 1987
- Cell population kinetics in the intestinal epithelium of the mouseExperimental Cell Research, 1959